title: Biomarkers in Parkinson disease: It's time to combine.
authors.affiliation: From the Departments of Medicine (Neurology) and Electrical and Computer Engineering (M.J.M.), University of British Columbia, Vancouver, Canada; and Department of Neurosciences (G.M.P.), University of California, San Diego. martin.mckeown@ubc.ca.
authors.forename: Martin J
authors.initials: MJ
authors.lastname: McKeown
authors.affiliation: From the Departments of Medicine (Neurology) and Electrical and Computer Engineering (M.J.M.), University of British Columbia, Vancouver, Canada; and Department of Neurosciences (G.M.P.), University of California, San Diego.
authors.forename: Guerry M
authors.initials: GM
authors.lastname: Peavy
mesh_terms: D016229:Amyloid beta-Peptides / Q000134:cerebrospinal fluid*; D001921:Brain / Q000503:physiopathology*; D005260:Female; D006801:Humans; D008297:Male; D010300:Parkinson Disease / Q000503:physiopathology*; D010446:Peptide Fragments / Q000134:cerebrospinal fluid*; D051844:alpha-Synuclein / Q000134:cerebrospinal fluid*
chemical_list: D016229:Amyloid beta-Peptides; D010446:Peptide Fragments; D051844:alpha-Synuclein